Studies have revealed that human adenovirus-encoded E1A protein promotes cell proliferation through the targeted interaction with cellular proteins that act as key negative regulators of cell growth. The targets of E1A protein include the retinoblastoma tumor suppressor protein (pRb). Because p202, an interferon (IFN)-inducible murine protein (52-kDa), negatively regulates cell growth in part through the pRb/E2F pathway, we tested whether the p202 is a target of the adenovirusencoded E1A protein for functional inactivation. Here we report that the expression of E1A protein overcame p202-mediated inhibition of cell growth and this correlated with an alleviation of p202-mediated inhibition of the transcriptional activity of E2F. Furthermore, E1A protein relieved p202-mediated inhibition of the speci®c DNA-binding activity of E2F complexes, including those containing the pocket proteins. Additionally, the E1A protein bound to p202 both in vitro and in vivo and a deletion of four amino acids in the conserved region 2 (CR2) of E1A protein signi®cantly reduced the binding of E1A to p202. Interestingly, ectopic expression of p202 under reduced serum conditions signi®cantly reduced E1A-mediated apoptosis. Taken together, our observations provide support to the idea that the p202 and adenovirus E1A protein functionally counteract each other and E1A protein targets p202 to promote cell proliferation. Oncogene (2001) 20, 6828 ± 6839.
Introduction
Studies with human adenovirus 5 have revealed that the early region 1A (E1A) gene gives rise to two major, dierentially spliced mRNAs (12S and 13S) that encode proteins of 243 residues (243R) and 289 residues (289R), respectively (Flint and Shenk, 1997; Brockmann and Esche, 1995) . These proteins share Nand C-terminal sequences and dier only in a 46-amino acid internal region, which is unique to the longer E1A protein and referred to as conserved region 3 (CR3, residues 140 ± 188). The CR3 domain confers on the 289R protein an ability to stimulate transcription of both viral and cellular promoters (Brockmann and Esche, 1995) . Two other evolutionary conserved regions, CR1 (residues 40 ± 80) and CR2 (residues 121 ± 139), are common to both E1A proteins and also correspond to functional subdomains. Genetic analysis has shown that CR1 and CR2 are required for E1A-mediated transformation of cells (Zantema and van der Eb, 1995) . Furthermore, the CR1 and CR2 domains together with the non-conserved amino terminus of E1A are responsible for repression of enhancermediated transcription and induction of cellular DNA synthesis (Brockmann and Esche, 1995; Zantema and van der Eb, 1995) .
The E1A proteins are potent regulators of gene expression and cell function (Nevins, 1995) . In cultured cells, depending on the cell system, E1A proteins can function as a repressor of enhanced transcription, as a transcriptional activator, and as a modulator of cell growth, dierentiation and oncogenic transformation (Nevins, 1995; Jones, 1995; Condorelli and Giordano, 1997) . Additionally, the expression of E1A protein in human and murine cells, under reduced serum conditions, results in p53-dependent apoptosis (White, 1995) .
The way in which E1A proteins perturb cell-growth regulation is understood in large part from studies of their interactions with cellular proteins. Earlier studies indicated that E1A protein interacts with several cellular proteins, including the retinoblastoma tumor suppressor protein (pRb) and the related proteins p107 and p130 (Harlow et al., 1986; Ludlow and Skuse, 1995; Cress and Nevins, 1996; Sang and Giordano, 1997; Nevins et al., 1997) . The molecular function of E1A is in part based on its capacity to interfere with cellular protein-protein interactions (Peeper and Zantema, 1993) . As both E1A and various cellular targets bind to a site in pRb termed the pocket domain (in human pRb amino acids 379 ± 768), E1A can competitively disrupt complex formation between pRb and its cellular targets (Peeper and Zantema, 1993; Cress and Nevins, 1996) .
One of the targets of pRb is the transcription factor E2F (E2F-1 ± E2F-5) (Nevins, 1992; Dyson, 1998) .
Binding of pRb to E2F results in a protein complex, which binds to DNA but does not activate transcription of the E2F responsive genes (Weinberg, 1995) . In fact, it is shown to actively repress transcription of E2F-responsive genes (Weintraub et al., 1992; Zhang et al., 1999) . It has been demonstrated that adenovirus E1A protein can dissociate complexes between the transcription factor E2F-1 and pRb (Bagchi et al., 1990; Cress and Nevins, 1996) , and this dissociation of the E2F-pRb complex correlates with stimulation of the E2F-dependent transcription of S phase genes and cell cycle progression (Raychaudhuri et al., 1991; Cress and Nevins, 1996, Weinberg, 1996) .
p202 is an interferon-inducible primarily nuclear phosphoprotein (52-kDa) (Choubey et al., 1989; Choubey and Lengyel, 1993) . We have shown previously that the expression of p202 in transfected cells (both normal and cancer cells) slows down cell proliferation (Choubey and Lengyel, 1993, 1995; Lengyel et al., 1995; Choubey et al., 1996; Min et al., 1996; Gutterman and Choubey, 1999; Yan et al., 1999; Choubey, 2000) and modulates apoptosis (Choubey, 2000; Wang et al., 2000; D'Souza et al., 2001) . However, the molecular mechanisms by which p202 negatively regulates cell proliferation and modulates apoptosis remain to be elucidated.
p202 contains an LxCxE motif (where L is leucine, C is cysteine, E is glutamic acid, and x is any amino acid) to bind pRb pocket and it was found to bind pRb in vitro and in vivo Datta et al., 1996) . Furthermore, p202-mediated inhibition of cell growth depends on pRb (Hertel et al., 2000) . Additionally, in promoter-reporter assays and in stable cell lines ectopic expression of p202 results in inhibition of a subset of E2F (E2F-1/DP-1 and E2F-4/DP-1) responsive genes Choubey and Gutterman, 1997) . Furthermore, overexpression of E2F-4 in a colony formation assay partially overcomes p202-mediated inhibition of cell proliferation (Choubey and Gutterman, 1997) . Together, these observations provide support to the idea that p202 negatively regulates cell proliferation in part through the pRb/E2F pathway.
Because the expression of p202 in transfected cells negatively regulates cell proliferation in part through the pRb/E2F pathway (Choubey, 2000) , we tested whether p202 is a potential target of the adenovirusencoded E1A protein for functional inactivation. Our experiments revealed that the expression of human adenovirus 5 E1A protein partially alleviates p202-mediated inhibition of colony formation and relieves p202-mediated inhibition of the transcriptional activity of E2F-1. Additionally, E1A protein overcomes p202-mediated inhibition of the sequence-speci®c DNA binding activity of E2F complexes. Interestingly, E1A protein can bind to p202 both in vitro and in vivo and a deletion of four amino acids in the conserved region 2 of E1A protein, which is known to be necessary for E1A-mediated transformation of cells, reduces binding of E1A to p202. Moreover, under reduced serum conditions, overexpression of p202 signi®cantly reduces E1A-mediated apoptosis. Thus, our observations provide support to the idea that p202 and E1A functionally counteract each other and E1A targets p202 to promote cell proliferation.
Results
Expression of E1A protein partially overcomes p202-mediated inhibition of colony formation Expression of p202 in transfected cells results in a decrease in colony formation by retarding cell proliferation (Choubey and Lengyel, 1993; Choubey et al., 1996; Min et al., 1996; Gutterman and Choubey, 1999; Yan et al., 1999) . Because cell growth inhibition by p202, in part, depends on its ability to inhibit the transcriptional activity of E2F Choubey and Gutterman, 1997) , we tested whether the expression of adenovirus E1A protein aects the p202-mediated inhibition of cell growth. Consistent with our earlier results (Choubey and Lengyel, 1993; , transfection of a p202-expression plasmid in murine AKR-2B ®broblasts, in two independent experiments, resulted in very few G418-resistant colonies (1.2 ± 2.5%) as compared to vector alone (Table 1) . However, cotransfection of pRSV-E1A plasmid along with pCMV-202 resulted in signi®cantly more G418-resistant colonies than pCMV-202 alone. Furthermore, we noted that the expression of E1A in these cells resulted in a moderate decrease in the number of colonies. Although it remains to be seen how the expression of E1A in these cells results in a decrease in colony formation, our results clearly indicated that the expression of E1A partially overcomes p202-mediated inhibition of colony formation.
Expression of adenovirus 5 E1A protein alleviates p202-mediated inhibition of E2F-dependent transcriptional activity
In promoter-reporter assays, the expression of p202 in human C-33A cells results in an inhibition of the E2F (E2F-1 and E2F-4)-stimulated transcription Choubey and Gutterman, 1997) . There- Murine AKR-2B ®broblasts were transfected with the indicated expression plasmids as described in Materials and methods and cells were selected for G418-resistance. Colonies exhibiting G418-resistance were stained and counted. a G418-resistant colonies as a percentage of the number of colonies obtained using the pCMV vector are indicated as 100%. NT: not tested fore, we tested whether the expression of adenovirus E1A protein alleviates p202-mediated inhibition of the transcriptional activity of E2F. As shown in Figure 1a , transfection of a plasmid encoding E2F-1 into C-33A cells stimulated the activity of a reporter, whose expression was driven by the four E2F enhancers (compare column 2 with 1). As observed before Choubey and Gutterman, 1997) , transfection of a plasmid encoding p202 along with E2F-1 encoding plasmid resulted in decreases in the activity of E2F-responsive reporter (Figure 1a , compare column 3 with 2). However, the expression of adenovirus encoded E1A protein did not result in a decrease in the activity of reporter (Figure 1a , compare column 4 with 2). Interestingly, transfection of increasing amounts of E1A encoding plasmid along with p202 encoding plasmid completely alleviated p202-mediated decreases in the activity of E2F-responsive reporter ( Figure 1a , compare column 5 and 6 with 3). Notably, overexpression of p202 did not result in decreases in the levels of E2F-1 (Figure 1b) . Instead, as noted before , the expression of p202 resulted in moderate increases in the levels of E2F-1 (Figure 1b , compare lane 2 with 1). Additionally, the expression of adenovirus E1A protein did not result in decreases in the levels of E2F-1 and the transfected p202. Together, these experiments support the hypothesis that the expression of adenovirus E1A protein counteracts p202-mediated retardation of cell proliferation in part by alleviating p202-mediated inhibition of the transcriptional activity of E2F.
E1A protein can relieve p202-mediated inhibition of DNA-binding activity of E2F
Because binding of p202 to E2Fs (E2F-1 and E2F-4) correlates with an inhibition of the sequence-speci®c DNA binding activity of E2F complexes in gel mobility shift assays Choubey and Gutterman, 1997) , we tested if E1A could relieve p202-mediated inhibition of DNA-binding activity of E2F complexes. For this purpose, we used total cell extracts prepared from human C-33A cells, after transfecting with a p202-encoding plasmid or, as a control, empty vector (pCMV) and extracts were analysed for the speci®c DNA binding activity of E2F in gel mobility shift assays. As shown in Figure 2 , in extracts prepared from pCMV transfected cells, E2F protein complexes bound to a labeled oligonucleotide containing the E2F DNA binding consensus sequence (lane 4) and the complexes were competed well with 20-fold excess of cold oligonucleotide (compare lane 4 with 2). Furthermore, incubation of cellular extracts with sodium deoxycholate, which is shown to dissociate the`pocket' proteins from E2Fs (Bagchi et al., 1990) , revealed that in these extracts about half of the E2F DNA binding activity was detectable as`free' E2F (Figure 2 , compare lane 4 with 3) and the remaining activity was detected as in complex with the`pocket' proteins (with p107 and p130). Interestingly, as observed previously Choubey and Gutterman, 1997) , transfection of pCMV-202 plasmid in C-33A cells resulted in a signi®cant decrease in the sequence-speci®c DNA-binding activity of E2F Figure 1 Expression of adenovirus E1A results in alleviation of p202-mediated inhibition of the transcriptional activity of E2F-1. (a) Human C-33A cells were transfected with E2F 4 -luc (2.5 mg) and pRL-TK (0.25 mg) reporter plasmids along with pCMVmE2F-1 (2 mg; columns 2 ± 6), pCMV-202 (2 mg; columns 3, 5, and 6) or pCMV-E1A (4 mg, columns 4 and 5; 8 mg, column 6) as described in Materials and methods. The activity of the ®re¯y luciferase was determined 42 ± 44 h after transfections and the activity from cells transfected with vector alone is indicated as 1. The average of three assays is shown. Furthermore, as reported previously by others and us (Melamed et al., 1993; Choubey et al., 1996; Choubey and Gutterman, 1997) , the incubation of these extracts with EDTA restored the DNA binding activity of both free' E2F (compare lane 5 with 6) and E2F in complex with the`pocket' proteins. Additionally, the incubation of these extracts with the recombinant E1A protein also restored the DNA-binding activity of E2F, which was detected primarily as`free' E2F ( Figure 2 , compare lane 5 with 7). Incubation of extracts prepared from vector transfected cells with the recombinant E1A protein also resulted in`free' E2F but no increase in DNA binding activity of E2F was seen (data not shown). These results are, thus, consistent with the possibility that adenovirus E1A protein alleviates p202-mediated inhibition of the transcriptional activity of E2F in part by releasing the`free' E2F from p202-pocket protein-E2F complexes, which do not appear to bind DNA in gel mobility shift assays.
p202 binds to E1A protein in vitro and in vivo
In our attempts to understand the molecular mechanism(s) by which adenovirus 5 E1A protein antagonizes p202-mediated inhibition of cell growth, we tested if E1A protein binds to p202. For this purpose, we incubated 35 S-methionine labeled in vitrotranslated (IVT) E1A protein with glutathioneSepharose beads bound to GST, GST-p202 or GST-pRb (a positive control). The beads were washed and the bound proteins were analysed by SDS ± PAGE followed by¯uorography. This experiment revealed (see Figure 3a ) that the labeled E1A protein selectively bound to GST-p202 and GSTpRb. However, signi®cantly less binding was seen with GST-202 than GST-Rb (Figure 3a , compare lane 4 with 3). Conversely, to test if IVT-p202 can bind to E1A, we followed two approaches. In the ®rst approach, we incubated labeled p202 with glutathione-Sepharose beads alone or loaded with GST or GST-pRb (a positive control) or GST-E1A (289 residues). The beads were washed and the bound proteins were analysed by SDS ± PAGE followed bȳ uorography. This experiment revealed (see Figure  3b ) that labeled p202 selectively bound to GST-E1A. Of note, the labeled p202 bound very eciently to GST-E1A as compared to GST -pRb ( Figure 3b , compare lane 5 with 4). In the second approach, we incubated labeled IVT-p202 with cellular extracts prepared from murine Pam212 keratinocytes expressing E1A (Pam212 E1A ), and immunoprecipitated proteins using monoclonal antibodies against SV40 large T (a negative control) or adenovirus E1A protein. This experiment revealed (see Figure 3c ) that p202 could form a speci®c complex with E1A protein in vitro.
To test if E1A expressed in cells can bind to p202, we incubated extracts from Pam212 E1A cells with GST or GST -p202 and analysed bound proteins by immunoblotting. This experiment revealed ( Figure 3d ) that E1A in cell extracts selectively bound to GST -p202. Conversely, p202 in extracts prepared from IFN-treated murine AKR-2B ®broblasts selectively bound to GST-E1A but not GST (Figure 3e ).
Since proteins present in a rabbit reticulocyte lysate or cellular extracts can act as an adapter for interaction between p202 and E1A protein , we incubated the recombinant puri®ed E1A (without GST) with GST, GST -pRb (a positive control), or GST -p202. The bound proteins were analysed by immunoblotting using monoclonal antibodies to E1A. This experiment revealed that interaction between p202 and E1A protein was as pronounced as between E1A and pRb (see Figure 3f) . Additionally, it also indicated that p202 may directly associate with E1A protein.
To determine if p202 associates with adenovirus E1a protein in vivo, we used two approaches. In the ®rst approach, we tested whether p202 could be coimmunoprecipitated with E1A protein from extracts prepared from murine Pam 212 E1A cells. As shown in Figure 4a , a p202 size protein (52-kDa) was coimmunoprecipitated with E1A protein. Furthermore, the levels of this protein increased after the treatment of cells with IFN (Figure 4a , compare lane 4 with 3). As a positive control, we also tested whether this protein could be coimmunoprecipitated with pRb (p202 binds to pRb; Choubey and Lengyel, 1995) . As shown in Figure 4 , a p202 size protein was coimmunoprecipitated with pRb from extracts prepared from Pam 212 cells and, as expected, the IFNtreatment of cells increased the levels of this protein (compare lane 6 with 5). In the second approach, we used two stable cell lines of Pam 212 E1A cells (cell line PE-4 and PE-8; see Figure 4b ), allowing stable overexpression of p202. Using extract prepared from these cell lines we found that p202 was coimmunoprecipitated with E1A from cells overexpressing p202. However, we could not detect p202 in immunoprecipitates recovered from the extracts prepared from vector transfected Pam 212 E1A cells (Figure 4b , compare lane 2 with 3). This observation indicated that under our immunoprecipitation/immunoblotting conditions the basal levels of p202 could not be detected in immunoprecipitates of E1A. Together, these observations provide support for the idea that adenovirus E1A protein binds to p202 both in vitro and in vivo. Interaction between E1A and p202 in vitro. (a) Binding of E1A to glutathione-Sepharose beads bound to GST-p202. In vitro-translated labeled E1A (10 ml of reaction mix) was incubated with glutathione-Sepharose beads bound to GST (lane 2) or GST-p202 (lane 3) or GST-mpRb (lane 4). The bound proteins were analysed by SDS ± PAGE followed by¯uorography. As a control, 10 ml of reaction mix was also loaded in lane 1 (IVT-E1A). An arrow indicates the full-length E1A protein band. (a short exposure for lane 1 is shown to see the full-length E1A protein) (b) Binding of p202 to glutathione-Sepharose beads bound to GST-E1A. In vitro-translated labeled p202 (10 ml of reaction mix) was incubated with glutathione-Sepharose beads (lane 2) or beads bound to GST (lane 3) or GST-pRb (lane 4) or GST-E1A (13S) (lane 5). The bound proteins were analysed as described in (a). As a control, 2 ml of reaction mix was also loaded in lane 1 (IVT-p202). An arrow indicates the full-length p202 protein band. (c) p202 associates with E1A expressed in cells. Extracts from murine Pam212 E1A keratinocytes containing equal amounts (200 mg) of proteins were incubated with labeled in vitro-translated p202 (10 ml of reaction mix) and proteins were immunoprecipitated using monoclonal anti-large T-antigen (lane 2) or anti-E1A protein (lane 3). As a control, labeled p202 was run in lane 2. An arrow indicates the full-length p202 protein band. The regions of adenovirus E1A protein that are required for promotions of cell proliferation coincide with those required for the binding to cellular proteins (Kaelin et al., 1990; Whyte et al., 1988; Cress and Nevins, 1996) . These include the conserved regions (CR) 1 and 2. To identify p202 binding region in E1A, we utilized various deletion mutants of adenovirus E1A protein, including those lacking the CR2 domain (mutant GST-E1A (1-105)) or having a deletion of four critical amino acids in CR2 domain (mutant GST-E1A (1 ± 289; dl124 ± 127)), needed for ecient binding to pRb (Fattaey et al., 1993) . As seen in Figure 5 (upper panel), a C-terminal truncated segment of E1A (GST-E1A (1 ± 150)) was sucient to bind p202 in vitro, indicating that in human adenovirus 5 E1A the amino acids 150 ± 289 were dispensable for binding to p202. Interestingly, a deletion of CR2 region in E1A (mutant GST-E1A (1 ± 105)) or just four amino acids from it (mutant (GST-E1A (1 ± 289; 124 ± 127)) resulted in signi®cantly reduced binding of E1A to p202 (see Figure 5 , lower panel). Thus, this result suggested that CR2 domain in E1A protein is a main binding site for p202.
Expression of p202 reduces adenovirus E1A-mediated apoptosis
The expression of adenovirus E1A protein in cultured cells, under reduced serum conditions, sensitizes them for apoptosis (White, 1995) . Because overexpression of p202, under reduced serum conditions, negatively regulates c-myc-induced apoptosis (Wang et al., 2000) and also inhibits p53-induced apoptosis (D'Souza et al., 2001), we tested whether overexpression of p202 aects E1A-induced apoptosis. For this purpose, we chose the murine Pam212 E1A cell line because these cells undergo apoptosis under reduced serum conditions (D Choubey, unpublished data). We transfected these cells with vector alone or p202-encoding plasmid and established stable cell lines overexpressing p202. We used two such independently selected stable cell lines PE-4 and PE-8, which constitutively overexpress p202 (see Figure 4b ). As shown in Figure 6a Figure 6a , bottom right panel for cell line PE-4; data for cell line PE-8 not shown). Flow cytometry of these cells to quantitate the presence of sub-G 1 cells revealed that overexpression of p202 in these cells after 48 h of incubation in reduced serum signi®cantly (in the case of PE-4 cell line about 36% and in the case of PE-8 about 33%) reduced the extent of sub-G 1 cells (Figure  6c, d) . Additionally, the analysis of DNA content from both adherent and¯oating cells in these cultures, which were transfected with empty vector, revealed that these cells under reduced serum condition exhibited signi®-cant laddering of chromosomal DNA, a hallmark of apoptosis. Furthermore, consistent with the¯ow cytometry data (Figure 6d ), overexpression of p202 in these two cell lines (PE-4 and PE-8) under reduced serum condition signi®cantly reduced the extent of DNA laddering (Figure 6e , compare lane 4 with lanes 5 or 6). Thus, these experiments provide support to the idea that overexpression of p202 in these cells negatively regulates the adenovirus E1A-mediated apoptosis.
Discussion
Human adenoviruses have been a powerful tool for studying cellular processes such as the regulation of gene expression and cell cycle progression (Schneider and Shenk, 1987; Zantema and van der Eb, 1995) . In particular, the analysis of the viral proteins encoded by the early region 1A (E1A), has provided many insights concerning the ability of adenoviruses to regulate not only their own genes, but also those of their hosts, which are generally quiescent cells. In order for the virus to achieve maximal replication, it must induce S phase entry, and E1A alone can achieve this (Nevins, 1995) . E1A is also capable of inducing immortalization or transformation of primary cells, the latter in cooperation with other oncogenes (Lillie et al., 1986; Jansen-Durr, 1996) .
Studies with human adenovirus-encoded E1A protein have revealed that the E1A protein promotes entry into the S phase by targeted interactions with the key negative regulators of cell proliferation (Peeper and Zantema, 1993; Cress and Nevins, 1996) . These targets include members of the`pocket' family proteins. Binding of E1A to the`pocket' family proteins results in dissociation of transcription factor E2F (E2F/DP) from the`pocket' proteins (resulting in`free' E2F). Thè free' E2F then activates transcription of the S phase genes, resulting in the progression of the cell cycle. Because p202-mediated negative regulation of cell growth correlates with the binding of p202 to E2F (E2F-1 and E2F-4) and inhibition of the transcriptional activity of E2F, we tested whether human adenovirus-encoded E1A protein (289 residues) binds to p202 and overcomes p202-mediated retardation of cell proliferation.
In the present study we provide evidence that the expression of human adenovirus 5 E1A protein counteracts p202-mediated inhibition of cell proliferation and this correlates with an alleviation of p202-mediated inhibition of the transcriptional activity of E2F. Additionally, we demonstrate that E1A binds to p202 both in vitro and in vivo and CR2 domain in E1A protein is needed for ecient binding. Moreover, we show that overexpression of p202, under reduced serum conditions, signi®cantly reduces E1A-mediated apoptosis. Thus, our observations support the idea that the adenovirus E1A and p202 functionally counteract each other and E1A protein overcomes p202-mediated negative regulation of cell proliferation, in part, by 2) or PE-4 cell line (lanes 3 and 4) either incubated in medium containing 10% serum (lanes 1 and 3) or 0.1% serum (lanes 2 and 4) were subjected to immunoblotting using antibodies to E1A or beta-actin. 1 and 4) , cell line PE-4 (lanes 2 and 5) or PE-8 (lanes 3 and 6) were lysed to isolate DNA after 48 h of incubation either in 10% serum (lanes 1 ± 3) or in 0.1% serum (lanes 4 ± 6). The DNA was subjected to agarose gel electrophoresis. The gel was stained with ethidium bromide and photographed relieving p202-mediated transcriptional repression of the E2F activity.
The amino acid sequence of p202 contains an LxCxE motif, which is found in several pRb binding proteins (Weinberg, 1995) and we have shown that p202 binds to pRb (and the related proteins p107 and p130) Choubey and Gutterman, 1997) . Moreover, our observation that a point mutation (mutation 706) in the pRb pocket, which renders pRb functionally inactive in human cancers, resulted in a decreased binding of pRb to p202 , suggested that the pRb pocket is a main binding site for p202. Because adenovirus E1A protein utilizes the same pRb-binding motif LxCxE to bind pRb pocket (and the related proteins) to stimulate cell proliferation (Raychaudhuri et al., 1991; Cress and Nevins, 1996) , it is conceivable that the expression of E1A protein impairs interactions between pRb and p202, thus antagonizing p202's ability to retard cell proliferation. Consistent with this notion it was recently shown that p202-mediated inhibition of cell growth depends on the presence of functional Rb (Hertel et al., 2000) . Additionally, our observation that the CR2 domain (includes the motif LxCxE) in human adenovirus E1A protein is needed for ecient binding of E1A to p202 also raises the possibility that the sequestration of p202 by the adenovirus E1A protein inhibits p202's ability to negatively regulate cell proliferation.
Two other proteins (SV40 large T and human papillomavirus-encoded E7), that are structurally and functionally similar to adenovirus E1A proteins, have been shown to stimulate cell proliferation by dissociating the transcription factor E2F from pRb and the related proteins (Chellappan et al., 1992) . Because these proteins also contain a CR2 domain, we tested if these proteins can also bind to p202. Our experiments revealed that SV40 large T and human papillomavirusencoded E7 protein also bind to p202 in vitro (data not shown). Further work will be needed to test if the expression of these proteins also inhibits p202-mediated retardation of cell proliferation.
In addition to E2F (E2F-1 and E2F-4), p202 also modulates the transcriptional activity of c-Myc (Wang et al., 2000) , AP-1 (c-Fos and c-Jun; Min et al., 1996) , NF-kB (p50 and p65; Min et al., 1996) , p53 , MyoD, and myogenin (Datta et al., 1998) . Therefore, it is likely that the binding of E1A to p202 also aects p202's ability to modulate the activities of these factors. Further work is in progress to test this interesting possibility.
Our observation that overexpression of p202 in murine keratinocytes under reduced serum conditions reduces E1A-mediated apoptosis is consistent with our earlier observations in which we found that the decreased levels of p202 in murine ®broblasts under reduced serum conditions increase the susceptibility to apoptosis (Koul et al., 1998) and overexpression of p202 in Rat-1 cells inhibits c-Myc-induced apoptosis (Wang et al., 2000) . Together, these observations provide support to the idea that increased levels of p202, under reduced serum conditions, are needed for cell survival. Consistent with this notion, we recently found that p202 levels increase under reduced serum conditions and the presence of serum growth factors in the culture medium negatively regulates the levels of the 202 RNA and protein .
While it remains to be seen how p202 inhibits E1A-mediated apoptosis, our observations that the increased cellular levels of p202 negatively regulate the transcriptional activity of p53 and other factors (including the E2F) (Choubey, 2000) , which are shown to collaborate with adenovirus E1A protein to induce apoptosis (De Stancina et al., 1998) , make it conceivable that the ability of p202 to inhibit the activity of these factors contributes to the inhibition of adenovirus E1A-mediated apoptosis.
Mouse adenovirus type 1 E1A protein (MAV-1 E1A), like E1A of human adenoviruses, contains the CR2 domain (motif DLxCxE), which allows it to bind the pocket of pRb and p107 (Smith et al., 1996) . We thus tested whether MAV-1 E1A can bind to p202. This experiment revealed that MAV-1 E1A also binds to p202 in GST pull-down assays (data not shown). This observation is consistent with the possibility that in murine cells p202 may be a target of MAV-1 E1A protein.
While p202 is a murine protein, there are indications that a structural and functional homologue of p202 is expressed in several human tissues that comprise epithelial cells . Therefore, the question arises what does the virus gain through the binding of E1A to p202? For adenovirus itself, the modulation may be important for its replication. The major cell targets for human adenovirus infection are epithelial cells lining the upper respiratory tract or the intestine in which proliferation is inhibited or tightly regulated. One of the major goals of viral early protein expression must be to alter the physiological state of these cells and to drive them into S phase (nuclear DNA replication). In this way, the viral oncogene creates an intracellular environment that is more permissive for viral DNA synthesis. The E1A proteins have been shown to stimulate host DNA synthesis and the virus may achieve this by antagonizing the function of cell proteins like p202 and others that normally serve to constrain cell growth.
In addition to the regulation of cell proliferation, p202 also modulates other cellular processes, such as dierentiation and apoptosis (Choubey, 2000) . Therefore, it is conceivable that binding of adenovirus E1A to p202 also antagonizes these other functions of p202. Further work will be needed to test these interesting possibilities.
Our observations raise the possibility that the adenovirus E1A and functionally similar proteins (for example, SV40 large T antigen and human papillomavirus E7 protein) bind and inactivate p202, an interferon-inducible negative regulator of cell growth, to overcome IFN-mediated growth-inhibitory (and perhaps antiviral) eects. Because the induction of p202 by IFN does not appear to depend on IFN-activatable transcription factor ISGF3 (Choubey, 2000) , which has been shown to be a target for human adenovirus E1A-mediated transcriptional repression of the IFN-activatable genes (Kalvakolanu et al., 1991; Ackrill et al., 1991) , and p202 can be induced by IFN treatment in murine cells expressing the adenovirus E1A (D Choubey, unpublished data), the functional inactivation of p202 by adenovirus E1A protein may provide adenoviruses with an additional mechanism to counteract the IFN action. Further work will be needed to examine this possibility.
Materials and methods

Cell lines and growth conditions
Murine embryonic AKR-2B ®broblasts (originally from Dr HL Moses, Vanderbilt University, Nashville, TN, USA), murine keratinocytes Pam212 and Pam212 transfected with a plasmid encoding adenovirus 5 E1A protein (Pam212 E1A ) (Missero et al., 1991) were from Dr Paolo Dotto (Harvard Medical School, Boston, MA, USA), human cervical carcinoma C-33A cells (from American Type Culture Collection), were grown in DMEM supplemented with 10% fetal bovine serum. When indicated, the cells were treated with recombinant IFN (Universal Type-1, Research Diagnostic, Inc., Flanders, NJ, USA) (1,000 U/ml 71 ) as described previously (Choubey and Lengyel, 1992) .
Plasmids and transfections
The pCMV-202 and pCMV plasmids have been described previously . Plasmids to express GST, and GST-mpRB have also been described previously . Dr J Nevins (Duke University, Durham, NC, USA) generously provided pCMV-E1A. Plasmid encoding GST-E1A was constructed by ligating E1A cDNA isolated from the plasmid pMALcr-1. E1A (13S) (generously provided by Dr Joe Germino, Department of Human Genetics, Yale University) into the pGEX vector resulting in the plasmid pGEX-E1A encoding adenovirus 5 E1A protein (289 residues). The Cterminal deletions in E1A protein used in the present study were generated by digesting the E1A cDNA with the restriction enzyme SmaI (deleting amino acids 150 ± 289) or StyI (deleting amino acids 105 ± 289) and eliminating the small DNA fragment and religation of the plasmid. Dr PE Branton (McGill University, Canada) generously provided plasmids encoding the deletion mutants GST-E1A (1 ± 289, dl 4 ± 25) and GST-E1A (1 ± 289, dl 124 ± 127). Plasmid pGSTmE1A (unpublished, Fang and Spindler, University of Georgia) encodes full-length mouse adenovirus type 1 E1A (aa 1 ± 200) fused downstream of GST protein in plasmid pGEX4T-1.
Colony formation assays
For colony formation assays, murine AKR-2B ®broblasts (*10 6 cells in 100-mm plate) were transfected with the indicated plasmid by calcium phosphate precipitation method. For cotransfections, pCMV-202 expression plasmid DNA (2 mg) was mixed with pCMV plasmid DNA (2 mg) or pRSVE1A plasmid DNA (2 mg). Following 24-h transfections, cells were dispersed with trypsin-EDTA treatment and seeded into three 100 mm diameter plates. Cells were selected in 500 mg/ml of G418 for about 2 weeks and colonies exhibiting G418-resistance were stained with crystal violet. Colonies with a diameter of about 1.5 ± 2-mm were counted for further analyses.
Flow cytometric analysis
Flow cytometry was performed on single cell suspensions on adherent (after trypsin/EDTA treatment) as well as thē oating cells after pooling them. Brie¯y, for cell cycle analysis cells were stained with propidium iodide (50 mg/ml, Sigma) and subjected to¯ow cytometry using Coulter Epics XLMCL¯ow cytometer as described previously (Chaturvedi et al., 1999) . Apoptosis was measured by the accumulation of cells with a sub-G 1 DNA content.
Protein-protein interactions using glutathione-Sepharose beads loaded with GST-fusion proteins
The GST fusion proteins were expressed in Escherichia coli BL21 and anity puri®ed as described previously . The glutathione-Sepharose beads were loaded with *0.5 mg of the indicated GST fusion protein, blocked in blocking buer (0.25% gelatin, 50 mm KCl, 50 mM HEPES, pH 7.5) at room temperature for 30 min, washed in binding buer (150 mM NaCl, 50 mM HEPES, pH 7.5, 0.1% NP-40), and used for anity chromatography.
Extracts from cultured cells were prepared in ice-cold extraction buer (50 mM HEPES, pH 7.5, 1% Nonidet P-40, 100 mM NaF, 0.2 mM orthovanadate, 100 mg ml 71 (leupeptin, 1 mM PMSF supplemented with 250 mM NaCl). The extracts were diluted twofold with the extraction buer without NaCl for binding to glutathione-Sepharose beads loaded with the indicated GST-fusion protein.
Aliquots (10 ml) from the reaction mixtures in which 35 Smethionine-labeled proteins had been translated in vitro were incubated with washed glutathione-Sepharose beads (loaded with the indicated GST fusion protein) in binding buer at room temperature for 30 min. The beads were washed four times in binding buer, and the bound proteins were released by boiling in 16protein sample buer and subjected to SDS ± PAGE followed by¯uorography.
Aliquots from the cell extracts (which had been diluted twofold with the extraction buer without NaCl) were incubated at 48C for 90 min with glutathione-Sepharose beads with the indicated GST fusion protein. The beads were washed ®ve times in extraction buer (supplemented with 150 mm NaCl) and boiling in 16protein sample buer eluted the bound proteins.
The puri®ed polyhistidine-tagged E1A protein (from Santa Cruz, Inc.) (0.5 mg) was incubated with GST, GST-mpRB or GST-p202 in binding buer as described above and the bound protein was detected by immunoblotting using monoclonal antibodies to E1A protein.
Immunoblotting
Cells were collected from plates in PBS, resuspended in modi®ed RIPA lysis buer (50 mM Tris-HCl, pH 8.0; 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate, 250 mM NaCl) supplemented with protease inhibitors (leupeptin, 50 mg ml 71 Pepstatin A, 50 mg ml
71
, PMSF, 1 mM), and incubated at 48C for 30 min. Lysates were sonicated brie¯y before centrifugation at 14 0006g in a microfuge for 10 min. Supernatants were collected and equal amounts of proteins were processed for immunoblotting as described previously (Choubey and Lengyel, 1993) . Polyclonal anti-p202 antiserum and the immunoanity-puri®ed anti-p202 antibodies have been described previously (Choubey and Lengyel, 1993) . Polyclonal antibodies against E1A protein (13S-5) for immunoblotting were from Santa Cruz Inc. (Santa Cruz, CA, USA).
Generation of labeled proteins
For generating labeled p202 or E1A proteins, mRNA were transcribed in vitro from plasmid pBluescript-202 and pBluescript-E1A, respectively. The mRNAs were used to translate proteins in vitro in rabbit reticulocyte lysate supplemented with 35 S-methionine as described previously .
Immunoprecipitations
Extracts from Pam 212
E1A or Pam 212 cells were prepared as described (Choubey and Lengyel, 1993) . For association of labeled p202 with E1A protein in vitro, labeled p202 was incubated with cellular extracts prepared from Pam212 E1A cells for 90 min at 48C and immunoprecipitations were done using monoclonal anti-E1A (clone M73, Oncogene Science). For labeling of proteins, Pam212
E1A or Pam 212 cells were treated with IFN (1000 U/ml) 24 h and cells were labeled with 35 S-methionine (0.5 mCi/ml; Amersham) for 4 h as described before (Choubey and Lengyel, 1993) . The extracts containing an equal number of counts were incubated with monoclonal anti-E1A (clone M73) or monoclonal pRb (clone G3-245) at 48C for 90 min. The complexes were recovered by binding to protein A/G-Sepharose at 48C for 45 min. The beads were washed six times and the bound proteins were analysed by SDS ± PAGE followed by¯uorography.
Electrophoretic mobility shift assay (EMSA)
Transfections were performed using the Calcium Chloride method. Sub-con¯uent cultures of C-33A cells were transfected with pCMV-202 plasmid (10 mg per 150 mm cell culture plate) or pCMV. After 48 h of transfections, cells were lysed and the whole cell extracts containing equal amounts of proteins were used to perform the E2F-speci®c gel-shift assays as described previously .
Reporter assays
For reporter assays, sub-con¯uent human C-33A cells (in a 6-well plate) were transfected with the reporter plasmids E2F 4 -luc (2.5 mg) and pRL-TK (0.25 mg) along with the indicated plasmid using the calcium phosphate transfection system (Gibco-BRL Life Tech., Rockville, MD, USA), as suggested by the supplier. The total amount of plasmid was adjusted to 7.5 mg using plasmid pBluescript. After transfections, cells were incubated for 42 ± 48 h and the ®re¯y luciferase and Renilla luciferase activities were determined using DualLuciferase Reporter Assay kit (from Promega) and TD-20/ 20 luminometer (from Turner Designs). The ®re¯y-luciferase activity was normalized to the Renilla luciferase in order to control for variation in transfection eciencies. The luciferase activity in control vector transfected cells is shown as 1.
DNA-fragmentation assays
Assays were performed on single cell suspensions on adherent (after trypsin/EDTA treatment) as well as the¯oating cells after pooling them. Cells (about 2 ± 5610 5 ) were lysed in 20 ml of lysis buer (20 mM EDTA, 100 mM Tris-HCl, pH 8.0, 0.8% sodium dodecyl sulphate). To lysate 10 ml of RNase A/T1 cocktail mix (500 units/ml and 20 000 units/ml, respectively) was added and the mixture was incubated at 378C for 2 h. Proteinase K solution (10 ml of 20 mg/ml) was added and samples were incubated overnight at 508C. Samples were mixed with 66 DNA loading buer (30% glycerol and 0.25% bromo phenol blue) before their analysis on 1.5% agarose gel. The agarose gel was run at 2 V/cm until the dye reached to the end of gel. The gel was stained with ethidium bromide and photographed.
